0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global In Vitro Diagnostic (IVD) Products Market Research Report 2026
Published Date: 2026-03-05
|
Report Code: QYRE-Auto-26
Home | Market Reports
Global In Vitro Diagnostic IVD Products Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global In Vitro Diagnostic (IVD) Products Market Research Report 2026

Code: QYRE-Auto-26
Report
2026-03-05
Pages:122
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

In Vitro Diagnostic (IVD) Products Market Size

The global In Vitro Diagnostic (IVD) Products market was valued at US$ 86640 million in 2025 and is anticipated to reach US$ 114790 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

In Vitro Diagnostic (IVD) Products Market

In Vitro Diagnostic (IVD) Products Market

In Vitro Diagnostic (IVD) tests are a subset of medical devices. In vitro diagnostic products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions, including a determination of the state of health, in order to cure, mitigate, treat, or prevent disease or its sequelae. Such products are intended for use in the collection, preparation, and examination of specimens taken from the human body.
In vitro diagnostics are tests that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
The global healthcare spending contributes to ca. 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The IVD market plays a significant role in the HC industry, influencing over 60% of laboratorial decision-making. However, it only accounts for ca. 2% of total HC spending, signifying an enormous potential for cost-effective tests.
The primary driver of growth in the IVD market is the aging of the global population. In addition, prevalence of chronic diseases is anticipated to propel this growth. More, growing demand for point-of-care devices and rapid diagnostic testing and increasing willingness to pay for preventive care testing.
COVID-19 pandemic is expected to continue to positively impact the market in 2020, 2021 and 2022, Due to the relaxation of global epidemic supervision, the reduction of COVID-19 testing in the post-epidemic era will reduce the total market size.
The In Vitro Diagnostics (IVD) market is driven by several key factors, including the rising prevalence of chronic and infectious diseases, advancements in diagnostic technologies, and increasing demand for personalized medicine. Innovations such as next-generation sequencing (NGS), point-of-care testing, and AI-driven diagnostics are transforming the industry by enabling faster, more accurate, and cost-effective testing. Additionally, the growing emphasis on preventive healthcare and the expansion of healthcare access in emerging markets are further fueling market growth. Regulatory support for precision diagnostics and increased investment in R&D also play a significant role in driving the adoption of IVD products globally.
Despite these drivers, the market faces several challenges. Stringent regulatory requirements and the high cost of R&D and clinical validation pose significant barriers for both established players and new entrants. Market saturation in developed regions and price sensitivity in emerging markets make it difficult to balance innovation with affordability. Furthermore, the integration of new diagnostic tools with existing laboratory infrastructure and IT systems can be complex and costly. Lastly, competition from established players and the need for significant capital investment to scale production and distribution add to the challenges for companies operating in this space.
The classification of In-Vitro Diagnostics (IVDs) Products includes Molecular Diagnostics, Immuno Diagnostics, Chemistry Diagnostics, POCT and Other. In 2023, POCT accounted for a share of 24.25% in the global In-Vitro Diagnostics (IVDs) Products market. In addition, this product segment is poised to reach US$ 29524 million by 2030 from US$ 19941 million in 2023.
North Americas is the largest consumption place, with a consumption market share nearly 38.19% in 2023. Following North Americas, APAC is the second largest consumption place with the consumption market share of 32.8%.
This report delivers a comprehensive overview of the global In Vitro Diagnostic (IVD) Products market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding In Vitro Diagnostic (IVD) Products. The In Vitro Diagnostic (IVD) Products market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global In Vitro Diagnostic (IVD) Products market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist In Vitro Diagnostic (IVD) Products manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of In Vitro Diagnostic (IVD) Products Market Report

Report Metric Details
Report Name In Vitro Diagnostic (IVD) Products Market
Accounted market size in 2025 US$ 86640 million
Forecasted market size in 2032 US$ 114790 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Immuno Diagnostics
  • Chemistry Diagnostics
  • Molecular Diagnostics
  • POCT
  • Others
Segment by Application
  • Hospital
  • Laboratory
  • Household
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Hologic, LifeScan, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen, Mindray, Sinocare, Getein Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for In Vitro Diagnostic (IVD) Products companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is In Vitro Diagnostic (IVD) Products Market growing?

Ans: The In Vitro Diagnostic (IVD) Products Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the In Vitro Diagnostic (IVD) Products Market size in 2032?

Ans: The In Vitro Diagnostic (IVD) Products Market size in 2032 will be US$ 114790 million.

What is the In Vitro Diagnostic (IVD) Products Market share by type?

Ans: In 2023, POCT accounted for a share of 24.25% in the global In-Vitro Diagnostics (IVDs) Products market.

What is the In Vitro Diagnostic (IVD) Products Market share by region?

Ans: North Americas is the largest consumption place, with a consumption market share nearly 38.19% in 2023.

Who are the main players in the In Vitro Diagnostic (IVD) Products Market report?

Ans: The main players in the In Vitro Diagnostic (IVD) Products Market are Roche, Abbott, Danaher, Siemens Healthineers, Thermo Fisher Scientific, Sysmex, BioMerieux, QuidelOrtho, Becton Dickinson, Bio-Rad Laboratories, Hologic, LifeScan, Qiagen, Wuhan Easy Diagnosis, Wondfo, KHB, Hotgen, Mindray, Sinocare, Getein Biotech

What are the Application segmentation covered in the In Vitro Diagnostic (IVD) Products Market report?

Ans: The Applications covered in the In Vitro Diagnostic (IVD) Products Market report are Hospital, Laboratory, Household, Others

What are the Type segmentation covered in the In Vitro Diagnostic (IVD) Products Market report?

Ans: The Types covered in the In Vitro Diagnostic (IVD) Products Market report are Immuno Diagnostics, Chemistry Diagnostics, Molecular Diagnostics, POCT, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Immuno Diagnostics
1.2.3 Chemistry Diagnostics
1.2.4 Molecular Diagnostics
1.2.5 POCT
1.2.6 Others
1.3 Market by Application
1.3.1 Global In Vitro Diagnostic (IVD) Products Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Hospital
1.3.3 Laboratory
1.3.4 Household
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In Vitro Diagnostic (IVD) Products Market Perspective (2021–2032)
2.2 Global In Vitro Diagnostic (IVD) Products Growth Trends by Region
2.2.1 Global In Vitro Diagnostic (IVD) Products Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 In Vitro Diagnostic (IVD) Products Historic Market Size by Region (2021–2026)
2.2.3 In Vitro Diagnostic (IVD) Products Forecasted Market Size by Region (2027–2032)
2.3 In Vitro Diagnostic (IVD) Products Market Dynamics
2.3.1 In Vitro Diagnostic (IVD) Products Industry Trends
2.3.2 In Vitro Diagnostic (IVD) Products Market Drivers
2.3.3 In Vitro Diagnostic (IVD) Products Market Challenges
2.3.4 In Vitro Diagnostic (IVD) Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In Vitro Diagnostic (IVD) Products Players by Revenue
3.1.1 Global Top In Vitro Diagnostic (IVD) Products Players by Revenue (2021–2026)
3.1.2 Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Players (2021–2026)
3.2 Global Top In Vitro Diagnostic (IVD) Products Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by In Vitro Diagnostic (IVD) Products Revenue
3.4 Global In Vitro Diagnostic (IVD) Products Market Concentration Ratio
3.4.1 Global In Vitro Diagnostic (IVD) Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In Vitro Diagnostic (IVD) Products Revenue in 2025
3.5 Global Key Players of In Vitro Diagnostic (IVD) Products Head Offices and Areas Served
3.6 Global Key Players of In Vitro Diagnostic (IVD) Products, Products and Applications
3.7 Global Key Players of In Vitro Diagnostic (IVD) Products, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 In Vitro Diagnostic (IVD) Products Breakdown Data by Type
4.1 Global In Vitro Diagnostic (IVD) Products Historic Market Size by Type (2021–2026)
4.2 Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Type (2027–2032)
5 In Vitro Diagnostic (IVD) Products Breakdown Data by Application
5.1 Global In Vitro Diagnostic (IVD) Products Historic Market Size by Application (2021–2026)
5.2 Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America In Vitro Diagnostic (IVD) Products Market Size (2021–2032)
6.2 North America In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America In Vitro Diagnostic (IVD) Products Market Size by Country (2021–2026)
6.4 North America In Vitro Diagnostic (IVD) Products Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In Vitro Diagnostic (IVD) Products Market Size (2021–2032)
7.2 Europe In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2021–2026)
7.4 Europe In Vitro Diagnostic (IVD) Products Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size (2021–2032)
8.2 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2021–2026)
8.4 Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America In Vitro Diagnostic (IVD) Products Market Size (2021–2032)
9.2 Latin America In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2021–2026)
9.4 Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size (2021–2032)
10.2 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2021–2026)
10.4 Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche In Vitro Diagnostic (IVD) Products Introduction
11.1.4 Roche Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott In Vitro Diagnostic (IVD) Products Introduction
11.2.4 Abbott Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.2.5 Abbott Recent Development
11.3 Danaher
11.3.1 Danaher Company Details
11.3.2 Danaher Business Overview
11.3.3 Danaher In Vitro Diagnostic (IVD) Products Introduction
11.3.4 Danaher Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.3.5 Danaher Recent Development
11.4 Siemens Healthineers
11.4.1 Siemens Healthineers Company Details
11.4.2 Siemens Healthineers Business Overview
11.4.3 Siemens Healthineers In Vitro Diagnostic (IVD) Products Introduction
11.4.4 Siemens Healthineers Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.4.5 Siemens Healthineers Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Details
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific In Vitro Diagnostic (IVD) Products Introduction
11.5.4 Thermo Fisher Scientific Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Sysmex
11.6.1 Sysmex Company Details
11.6.2 Sysmex Business Overview
11.6.3 Sysmex In Vitro Diagnostic (IVD) Products Introduction
11.6.4 Sysmex Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.6.5 Sysmex Recent Development
11.7 BioMerieux
11.7.1 BioMerieux Company Details
11.7.2 BioMerieux Business Overview
11.7.3 BioMerieux In Vitro Diagnostic (IVD) Products Introduction
11.7.4 BioMerieux Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.7.5 BioMerieux Recent Development
11.8 QuidelOrtho
11.8.1 QuidelOrtho Company Details
11.8.2 QuidelOrtho Business Overview
11.8.3 QuidelOrtho In Vitro Diagnostic (IVD) Products Introduction
11.8.4 QuidelOrtho Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.8.5 QuidelOrtho Recent Development
11.9 Becton Dickinson
11.9.1 Becton Dickinson Company Details
11.9.2 Becton Dickinson Business Overview
11.9.3 Becton Dickinson In Vitro Diagnostic (IVD) Products Introduction
11.9.4 Becton Dickinson Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.9.5 Becton Dickinson Recent Development
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Details
11.10.2 Bio-Rad Laboratories Business Overview
11.10.3 Bio-Rad Laboratories In Vitro Diagnostic (IVD) Products Introduction
11.10.4 Bio-Rad Laboratories Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.10.5 Bio-Rad Laboratories Recent Development
11.11 Hologic
11.11.1 Hologic Company Details
11.11.2 Hologic Business Overview
11.11.3 Hologic In Vitro Diagnostic (IVD) Products Introduction
11.11.4 Hologic Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.11.5 Hologic Recent Development
11.12 LifeScan
11.12.1 LifeScan Company Details
11.12.2 LifeScan Business Overview
11.12.3 LifeScan In Vitro Diagnostic (IVD) Products Introduction
11.12.4 LifeScan Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.12.5 LifeScan Recent Development
11.13 Qiagen
11.13.1 Qiagen Company Details
11.13.2 Qiagen Business Overview
11.13.3 Qiagen In Vitro Diagnostic (IVD) Products Introduction
11.13.4 Qiagen Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.13.5 Qiagen Recent Development
11.14 Wuhan Easy Diagnosis
11.14.1 Wuhan Easy Diagnosis Company Details
11.14.2 Wuhan Easy Diagnosis Business Overview
11.14.3 Wuhan Easy Diagnosis In Vitro Diagnostic (IVD) Products Introduction
11.14.4 Wuhan Easy Diagnosis Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.14.5 Wuhan Easy Diagnosis Recent Development
11.15 Wondfo
11.15.1 Wondfo Company Details
11.15.2 Wondfo Business Overview
11.15.3 Wondfo In Vitro Diagnostic (IVD) Products Introduction
11.15.4 Wondfo Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.15.5 Wondfo Recent Development
11.16 KHB
11.16.1 KHB Company Details
11.16.2 KHB Business Overview
11.16.3 KHB In Vitro Diagnostic (IVD) Products Introduction
11.16.4 KHB Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.16.5 KHB Recent Development
11.17 Hotgen
11.17.1 Hotgen Company Details
11.17.2 Hotgen Business Overview
11.17.3 Hotgen In Vitro Diagnostic (IVD) Products Introduction
11.17.4 Hotgen Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.17.5 Hotgen Recent Development
11.18 Mindray
11.18.1 Mindray Company Details
11.18.2 Mindray Business Overview
11.18.3 Mindray In Vitro Diagnostic (IVD) Products Introduction
11.18.4 Mindray Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.18.5 Mindray Recent Development
11.19 Sinocare
11.19.1 Sinocare Company Details
11.19.2 Sinocare Business Overview
11.19.3 Sinocare In Vitro Diagnostic (IVD) Products Introduction
11.19.4 Sinocare Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.19.5 Sinocare Recent Development
11.20 Getein Biotech
11.20.1 Getein Biotech Company Details
11.20.2 Getein Biotech Business Overview
11.20.3 Getein Biotech In Vitro Diagnostic (IVD) Products Introduction
11.20.4 Getein Biotech Revenue in In Vitro Diagnostic (IVD) Products Business (2021–2026)
11.20.5 Getein Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Immuno Diagnostics
 Table 3. Key Players of Chemistry Diagnostics
 Table 4. Key Players of Molecular Diagnostics
 Table 5. Key Players of POCT
 Table 6. Key Players of Others
 Table 7. Global In Vitro Diagnostic (IVD) Products Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global In Vitro Diagnostic (IVD) Products Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 9. Global In Vitro Diagnostic (IVD) Products Market Size by Region (US$ Million), 2021–2026
 Table 10. Global In Vitro Diagnostic (IVD) Products Market Share by Region (2021–2026)
 Table 11. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 12. Global In Vitro Diagnostic (IVD) Products Market Share by Region (2027–2032)
 Table 13. In Vitro Diagnostic (IVD) Products Market Trends
 Table 14. In Vitro Diagnostic (IVD) Products Market Drivers
 Table 15. In Vitro Diagnostic (IVD) Products Market Challenges
 Table 16. In Vitro Diagnostic (IVD) Products Market Restraints
 Table 17. Global In Vitro Diagnostic (IVD) Products Revenue by Players (US$ Million), 2021–2026
 Table 18. Global In Vitro Diagnostic (IVD) Products Market Share by Players (2021–2026)
 Table 19. Global Top In Vitro Diagnostic (IVD) Products Players by Tier (Tier 1, Tier 2, and Tier 3), based on In Vitro Diagnostic (IVD) Products Revenue, 2025
 Table 20. Ranking of Global Top In Vitro Diagnostic (IVD) Products Companies by Revenue (US$ Million) in 2025
 Table 21. Global 5 Largest Players Market Share by In Vitro Diagnostic (IVD) Products Revenue (CR5 and HHI), 2021–2026
 Table 22. Global Key Players of In Vitro Diagnostic (IVD) Products, Headquarters and Area Served
 Table 23. Global Key Players of In Vitro Diagnostic (IVD) Products, Products and Applications
 Table 24. Global Key Players of In Vitro Diagnostic (IVD) Products, Date of General Availability (GA)
 Table 25. Mergers and Acquisitions, Expansion Plans
 Table 26. Global In Vitro Diagnostic (IVD) Products Market Size by Type (US$ Million), 2021–2026
 Table 27. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Type (2021–2026)
 Table 28. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 29. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Type (2027–2032)
 Table 30. Global In Vitro Diagnostic (IVD) Products Market Size by Application (US$ Million), 2021–2026
 Table 31. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Application (2021–2026)
 Table 32. Global In Vitro Diagnostic (IVD) Products Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 33. Global In Vitro Diagnostic (IVD) Products Revenue Market Share by Application (2027–2032)
 Table 34. North America In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 35. North America In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2021–2026
 Table 36. North America In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2027–2032
 Table 37. Europe In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 38. Europe In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2021–2026
 Table 39. Europe In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2027–2032
 Table 40. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 41. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (US$ Million), 2021–2026
 Table 42. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size by Region (US$ Million), 2027–2032
 Table 43. Latin America In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 44. Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2021–2026
 Table 45. Latin America In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2027–2032
 Table 46. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 47. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2021–2026
 Table 48. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size by Country (US$ Million), 2027–2032
 Table 49. Roche Company Details
 Table 50. Roche Business Overview
 Table 51. Roche In Vitro Diagnostic (IVD) Products Product
 Table 52. Roche Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 53. Roche Recent Development
 Table 54. Abbott Company Details
 Table 55. Abbott Business Overview
 Table 56. Abbott In Vitro Diagnostic (IVD) Products Product
 Table 57. Abbott Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 58. Abbott Recent Development
 Table 59. Danaher Company Details
 Table 60. Danaher Business Overview
 Table 61. Danaher In Vitro Diagnostic (IVD) Products Product
 Table 62. Danaher Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 63. Danaher Recent Development
 Table 64. Siemens Healthineers Company Details
 Table 65. Siemens Healthineers Business Overview
 Table 66. Siemens Healthineers In Vitro Diagnostic (IVD) Products Product
 Table 67. Siemens Healthineers Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 68. Siemens Healthineers Recent Development
 Table 69. Thermo Fisher Scientific Company Details
 Table 70. Thermo Fisher Scientific Business Overview
 Table 71. Thermo Fisher Scientific In Vitro Diagnostic (IVD) Products Product
 Table 72. Thermo Fisher Scientific Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 73. Thermo Fisher Scientific Recent Development
 Table 74. Sysmex Company Details
 Table 75. Sysmex Business Overview
 Table 76. Sysmex In Vitro Diagnostic (IVD) Products Product
 Table 77. Sysmex Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 78. Sysmex Recent Development
 Table 79. BioMerieux Company Details
 Table 80. BioMerieux Business Overview
 Table 81. BioMerieux In Vitro Diagnostic (IVD) Products Product
 Table 82. BioMerieux Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 83. BioMerieux Recent Development
 Table 84. QuidelOrtho Company Details
 Table 85. QuidelOrtho Business Overview
 Table 86. QuidelOrtho In Vitro Diagnostic (IVD) Products Product
 Table 87. QuidelOrtho Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 88. QuidelOrtho Recent Development
 Table 89. Becton Dickinson Company Details
 Table 90. Becton Dickinson Business Overview
 Table 91. Becton Dickinson In Vitro Diagnostic (IVD) Products Product
 Table 92. Becton Dickinson Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 93. Becton Dickinson Recent Development
 Table 94. Bio-Rad Laboratories Company Details
 Table 95. Bio-Rad Laboratories Business Overview
 Table 96. Bio-Rad Laboratories In Vitro Diagnostic (IVD) Products Product
 Table 97. Bio-Rad Laboratories Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 98. Bio-Rad Laboratories Recent Development
 Table 99. Hologic Company Details
 Table 100. Hologic Business Overview
 Table 101. Hologic In Vitro Diagnostic (IVD) Products Product
 Table 102. Hologic Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 103. Hologic Recent Development
 Table 104. LifeScan Company Details
 Table 105. LifeScan Business Overview
 Table 106. LifeScan In Vitro Diagnostic (IVD) Products Product
 Table 107. LifeScan Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 108. LifeScan Recent Development
 Table 109. Qiagen Company Details
 Table 110. Qiagen Business Overview
 Table 111. Qiagen In Vitro Diagnostic (IVD) Products Product
 Table 112. Qiagen Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 113. Qiagen Recent Development
 Table 114. Wuhan Easy Diagnosis Company Details
 Table 115. Wuhan Easy Diagnosis Business Overview
 Table 116. Wuhan Easy Diagnosis In Vitro Diagnostic (IVD) Products Product
 Table 117. Wuhan Easy Diagnosis Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 118. Wuhan Easy Diagnosis Recent Development
 Table 119. Wondfo Company Details
 Table 120. Wondfo Business Overview
 Table 121. Wondfo In Vitro Diagnostic (IVD) Products Product
 Table 122. Wondfo Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 123. Wondfo Recent Development
 Table 124. KHB Company Details
 Table 125. KHB Business Overview
 Table 126. KHB In Vitro Diagnostic (IVD) Products Product
 Table 127. KHB Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 128. KHB Recent Development
 Table 129. Hotgen Company Details
 Table 130. Hotgen Business Overview
 Table 131. Hotgen In Vitro Diagnostic (IVD) Products Product
 Table 132. Hotgen Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 133. Hotgen Recent Development
 Table 134. Mindray Company Details
 Table 135. Mindray Business Overview
 Table 136. Mindray In Vitro Diagnostic (IVD) Products Product
 Table 137. Mindray Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 138. Mindray Recent Development
 Table 139. Sinocare Company Details
 Table 140. Sinocare Business Overview
 Table 141. Sinocare In Vitro Diagnostic (IVD) Products Product
 Table 142. Sinocare Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 143. Sinocare Recent Development
 Table 144. Getein Biotech Company Details
 Table 145. Getein Biotech Business Overview
 Table 146. Getein Biotech In Vitro Diagnostic (IVD) Products Product
 Table 147. Getein Biotech Revenue in In Vitro Diagnostic (IVD) Products Business (US$ Million), 2021–2026
 Table 148. Getein Biotech Recent Development
 Table 149. Research Programs/Design for This Report
 Table 150. Key Data Information from Secondary Sources
 Table 151. Key Data Information from Primary Sources
 Table 152. Authors List of This Report


List of Figures
 Figure 1. In Vitro Diagnostic (IVD) Products Picture
 Figure 2. Global In Vitro Diagnostic (IVD) Products Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global In Vitro Diagnostic (IVD) Products Market Share by Type: 2025 vs 2032
 Figure 4. Immuno Diagnostics Features
 Figure 5. Chemistry Diagnostics Features
 Figure 6. Molecular Diagnostics Features
 Figure 7. POCT Features
 Figure 8. Others Features
 Figure 9. Global In Vitro Diagnostic (IVD) Products Market Size by Application (US$ Million), 2021–2032
 Figure 10. Global In Vitro Diagnostic (IVD) Products Market Share by Application: 2025 vs 2032
 Figure 11. Hospital Case Studies
 Figure 12. Laboratory Case Studies
 Figure 13. Household Case Studies
 Figure 14. Others Case Studies
 Figure 15. In Vitro Diagnostic (IVD) Products Report Years Considered
 Figure 16. Global In Vitro Diagnostic (IVD) Products Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 17. Global In Vitro Diagnostic (IVD) Products Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 18. Global In Vitro Diagnostic (IVD) Products Market Share by Region: 2025 vs 2032
 Figure 19. Global In Vitro Diagnostic (IVD) Products Market Share by Players in 2025
 Figure 20. Global In Vitro Diagnostic (IVD) Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 21. The Top 10 and 5 Players Market Share by In Vitro Diagnostic (IVD) Products Revenue in 2025
 Figure 22. North America In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. North America In Vitro Diagnostic (IVD) Products Market Share by Country (2021–2032)
 Figure 24. United States In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 25. Canada In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. Europe In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. Europe In Vitro Diagnostic (IVD) Products Market Share by Country (2021–2032)
 Figure 28. Germany In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. France In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. U.K. In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Italy In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Russia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 33. Ireland In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. Asia-Pacific In Vitro Diagnostic (IVD) Products Market Share by Region (2021–2032)
 Figure 36. China In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. Japan In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. South Korea In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Southeast Asia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. India In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 41. Australia & New Zealand In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Latin America In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Latin America In Vitro Diagnostic (IVD) Products Market Share by Country (2021–2032)
 Figure 44. Mexico In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 45. Brazil In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. Middle East & Africa In Vitro Diagnostic (IVD) Products Market Share by Country (2021–2032)
 Figure 48. Israel In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 49. Saudi Arabia In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 50. UAE In Vitro Diagnostic (IVD) Products Market Size YoY Growth (US$ Million), 2021–2032
 Figure 51. Roche Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 52. Abbott Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 53. Danaher Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 54. Siemens Healthineers Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 55. Thermo Fisher Scientific Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 56. Sysmex Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 57. BioMerieux Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 58. QuidelOrtho Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 59. Becton Dickinson Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 60. Bio-Rad Laboratories Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 61. Hologic Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 62. LifeScan Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 63. Qiagen Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 64. Wuhan Easy Diagnosis Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 65. Wondfo Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 66. KHB Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 67. Hotgen Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 68. Mindray Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 69. Sinocare Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 70. Getein Biotech Revenue Growth Rate in In Vitro Diagnostic (IVD) Products Business (2021–2026)
 Figure 71. Bottom-up and Top-down Approaches for This Report
 Figure 72. Data Triangulation
 Figure 73. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS